Key decision points organizations face when evaluating SEND outsourcing Introduction As SEND continues to play a critical role in U.S. FDA submissions, organizations are increasingly evaluating how best to manage SEND activities across studies. While some teams build internal capabilities, others rely on external partners or adopt a hybrid approach. The right model often depends on factors such as study volume, timelines, internal expertise, and regulatory expectations. In pr